EN DE

Ganesh Benzoplast Limited (GANESHBE) Fair Value & Analysis

Basic Materials · IN · Market cap ₹7.5B

GB Ganesh Benzoplast Limited GANESHBE · NSE
Price₹117.65
Fair Value₹127.24
Upside+8.2%
Quality48/100
Watch Ganesh Benzoplast Limited for free, get notified when fair value or trend changes. Watch for free
Expensive Growth
Solidly profitable · 17.8% net margin
Low debt · generates free cash flow
Ranks above peers (11/13)
Moderate moat 55/100
Evidence: High Range ₹69.27 – ₹165.41 Share as image

Fair value as of: Aug 13, 2026

From 24 valuation models · updated 3 days ago

Share price +13.3% over the past month.

Below-average quality, currently priced close to our fair value.

Fair value for all 35,000+ stocks, review alerts and the diversification check: 14 days of Pro free, no card.

What matters now

  • The price sits close to our fair value, market and models broadly agree here, little valuation tension.
  • A fairly wide model range (₹69.27 to ₹165.41) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

₹211.45 ₹69.52 Fair Value ₹127.24 Sep 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

59‑month range ₹69.52 – ₹211.45 · fair‑value band ₹69.27 – ₹165.41 · the ₹117.65 price screens below the ₹127.24 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Ganesh Benzoplast Limited (GANESHBE) currently trades at ₹117.65, while our model-based Fair Value estimate is ₹127.24, implying the stock looks roughly 8.2% fairly valued today. The Quality Score stands at 48/100 (below-average quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, Ganesh Benzoplast Limited generated revenue of ₹4.1B at a net margin of 17.8%. Revenue grew 11.5% year over year. It earns a return on equity of 12.6%. The balance sheet holds a net cash position of ₹36.9M. Fundamentals as of Aug 13, 2026

Our scenario range runs from ₹69.27 (bear case) to ₹165.41 (bull case); at ₹117.65, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades near its 52-week high and 72% above its 52-week low, currently above its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -68% fair-value upside, at 8%, GANESHBE screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF ₹26.67 ₹38.00 ₹56.43 80
Rev-Margin DCF ₹56.01 ₹97.99 ₹152.74 74
ROIC Compounder ₹67.75 ₹76.71 ₹84.44 72
All 24 models by family
DCF Models
FCF DCF ₹26.87 ₹39.52 ₹60.98 38
Owner Earnings ₹67.93 ₹113.35 ₹190.47 31
5Y Revenue Exit ₹56.01 ₹100.09 ₹161.92 39
5Y EBITDA Exit ₹76.53 ₹142.83 ₹228.35 41
5Y P/E Exit ₹96.56 ₹184.56 ₹287.84 38
10Y Revenue Exit ₹43.70 ₹81.71 ₹143.44 36
10Y EBITDA Exit ₹59.05 ₹112.51 ₹198.36 37
10Y P/E Exit ₹72.10 ₹142.58 ₹247.54 35
Earnings-Based
Graham-Dodd ₹69.27 ₹333.48 ₹459.14 54
Lynch FV ₹89.07 ₹127.24 ₹165.41 50
PEG = 1.0 ₹89.07 ₹127.24 ₹165.41 46
EPV ₹67.75 ₹76.71 ₹84.44 59
Multiples
P/E Multiple ₹129.88 ₹173.18 ₹216.47 63
P/S Multiple ₹64.29 ₹85.72 ₹107.16 58
P/B Multiple ₹129.88 ₹173.18 ₹216.47 55
EV/EBIT ₹112.54 ₹146.38 ₹180.21 53
EV/EBITDA ₹108.52 ₹141.01 ₹173.51 54
EV/Revenue ₹71.04 ₹96.76 ₹122.48 43
Asset-Based
NCAV (Graham) ₹42.43 ₹56.86 ₹84.87 50
Growth DCF
Growth DCF ₹26.67 ₹38.00 ₹56.43 80
Rev-Margin DCF ₹56.01 ₹97.99 ₹152.74 74
Economic Profit
Residual Income ₹77.40 ₹90.27 ₹172.76 61
ROIC Compounder ₹67.75 ₹76.71 ₹84.44 72
Growth Earnings
Growth-Adj P/E ₹124.73 ₹178.19 ₹231.64 68

Widest divergence: Growth Earnings (₹178.19) versus Growth DCF (₹38.00). Highest evidence: Growth DCF (80).

Notify me when GANESHBE reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) ₹4.1B
Revenue growth (YoY) +11.5%
Net margin 17.8%
Return on equity 12.6%
Free cash flow ₹91.9M FY2026
P/E ratio 11.5
More key figures
Operating margin 12.9%
EPS (TTM) ₹10.19
EPS growth (YoY) -12.2%
Net cash ₹36.9M FY2026

Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 48/100

Of which business quality 50 · Market factors (momentum, volatility) 73

Profitability 53
Margins and returns on capital today
Quality Growth 46
Are margins and returns improving?
Cashflow 31
Earnings quality: real cash, not paper profit
Fin. Strength 82
Balance sheet, leverage, solvency risk
Investment 14
Disciplined investing over empire-building
Low Volatility 69
Calm price path (market factor)
Momentum 73
Price trend over the last 3–12 months (market factor)
52W Momentum 78
Distance to the 52-week high (market factor)
Net Issuance 63
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Ganesh Benzoplast Limited engages in the manufactures and sells specialty chemicals, food preservatives, and industrial lubricants in India and internationally. It operates through two segments, Liquid Storage Tanks and Chemical.

Full company description

Ganesh Benzoplast Limited engages in the manufactures and sells specialty chemicals, food preservatives, and industrial lubricants in India and internationally. It operates through two segments, Liquid Storage Tanks and Chemical. The company provides liquid storage tanks; engineering procurement and construction services; rail logistic services; storage and handling solutions; and transportation facilities. It offers lubricant additives that includes engine, driveline, and industrial lubricant additives; detergent/dispersant, antiwear/anti-oxidant, and other components; sodium, calcium, barium, and magnesium petroleum sulphonate chemicals; and other lube specialty chemicals, such as brake fluid. In addition, the company offers chemicals comprising sodium benzoate, benzoic acid, methyl benzoate, and benzoate plasticisers. Further, it provides bunkering, blending, and drum filling services. The company serves food and beverage, paints, automobile, pharmaceutical, and lubricants industries. Ganesh Benzoplast Limited was incorporated in 1986 and is headquartered in Mumbai, India.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

Ganesh Benzoplast Limited reported revenue of ₹4.1B in FY2026 versus ₹3.6B in FY2022, a compound +3.6%/yr. Reported net income was ₹733M in FY2026, compounding +22.4%/yr from FY2022.

Growth Quality 62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Latest Revenue (FY 2026)
₹4.1B
Latest YoY
+9.9%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−0.8%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+8.8%
Avg. growth/yr (20Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+12.6%
Revenue +3.6%/yr
FY22 ₹3.6B
FY23 ₹4.2B
FY24 ₹4.8B
FY25 ₹3.7B
FY26 ₹4.1B
Net income +22.4%/yr
FY22 ₹327M
FY23 ₹551M
FY24 ₹614M
FY25 ₹381M
FY26 ₹733M
Character of growth · EPS growth decomposed (2015-2026) +8.5 % p.a.
Revenue per share +11.1 pp

of which total revenue +15.0 pp · buybacks/dilution −3.9 pp

EBIT margin +0.9 pp
Tax rate −3.2 pp
Residual (interest, one-offs) −0.3 pp

Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).

Watch GANESHBE: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Ganesh Benzoplast Limited Fair Value". https://www.fairvalue-calculator.com/stock/GANESHBE

Peer Group

Specialty Chemicals · 670 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 48 · Below median
Fair Value upside +8% · Above median
Return on equity (TTM) 13% · Top 25%
Return on assets 6% · Top 25%
Net margin (TTM) 18% · Top 25%
Operating margin (TTM) 13% · Above median
Revenue growth 12% · Above median

Valuation Multiples vs Specialty Chemicals median · lower = cheaper

P/E (TTM) 11.5× · Cheaper than 75% of peers
P/B 1.22× · Cheaper than median
P/S (TTM) 1.81× · Pricier than median
P/FCF 0.9× · Cheaper than median
EV/EBITDA 7.1× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 44 · sector 0
FUTURE 58 · sector 19
PAST 50 · sector 23
HEALTH 100 · sector 95
DIVIDEND 0 · sector 32

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Stock Price Fair Value vs Fair Value
Linde plc LIN $479.43 $222.03 -54%
Wanhua Chemical Group 600309 ¥75.06 ¥68.03 -9%
Novozymes A/S NSISB kr 416.10 kr 170.02 -59%
Asian Paints Limited ASIANPAINT ₹2,756 ₹664.51 -76%
Solar Industries India Limited SOLARINDS ₹18,730 ₹2,793 -85%
Pidilite Industries Limited PIDILITIND ₹1,702 ₹351.84 -79%
PT Chandra Asri Pacific Tbk TPIA 2,160 IDR 2,322 IDR +8%
Berger Paints India Limited BERGEPAINT ₹559.80 ₹154.46 -72%
Gujarat Fluorochemicals Limited FLUOROCHEM ₹4,566 ₹836.47 -82%
Himadri Speciality Chemical Limited HSCL ₹778.15 ₹248.63 -68%

Compare Ganesh Benzoplast Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Ganesh Benzoplast Limited (GANESHBE) overvalued or undervalued?
As of Aug 13, 2026, our model estimates a fair value of ₹127.24 versus a price of ₹117.65, about +8% (fairly valued).
What is the fair value of GANESHBE?
Our model-based fair value for Ganesh Benzoplast Limited is ₹127.24 (as of Aug 13, 2026), built from audited fundamentals. The current price is ₹117.65.
What is the quality score of GANESHBE?
Ganesh Benzoplast Limited has a Quality Score of 48/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Ganesh Benzoplast Limited (GANESHBE)?
Ganesh Benzoplast Limited reported trailing-twelve-month revenue of about ₹4.1B (latest available figure, as of Aug 13, 2026).
What is the net profit margin of GANESHBE?
The net profit margin of Ganesh Benzoplast Limited is about 17.8%, meaning it keeps roughly 17.8% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Ganesh Benzoplast Limited and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.